New oxabispidine compounds for the treatment of cardiac arrhythmias

Details for Australian Patent Application No. 2006258293 (hide)

Owner AstraZeneca AB

Inventors Ensor, Gareth; Cladingboel, David; Lundqvist, Robert; Sigfridsson, CarlGustav; Bjore, Annika; Strandlund, Gert; Herring, Adam; Kajanus, Johan; Olsson, Christina

Agent Davies Collison Cave

Pub. Number AU-B-2006258293

PCT Pub. Number WO2006/135316

Priority 0502775-0 15.12.05 SE; PCT/ SE2005/000891 13.06.05 SE

Filing date 12 June 2006

Wipo publication date 21 December 2006

Acceptance publication date 17 June 2010

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5386 (2006.01)

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

17 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135316 Priority application(s): WO2006/135316

17 June 2010 Application Accepted

  Published as AU-B-2006258293

14 October 2010 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258300-Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives

2006258289-Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives